These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24009002)

  • 1. Risk estimates for complex disorders: comparing personal genome testing and family history.
    Aiyar L; Shuman C; Hayeems R; Dupuis A; Pu S; Wodak S; Chitayat D; Velsher L; Davies J
    Genet Med; 2014 Mar; 16(3):231-7. PubMed ID: 24009002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers.
    Heald B; Edelman E; Eng C
    Eur J Hum Genet; 2012 May; 20(5):547-51. PubMed ID: 22215421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry.
    Wu HC; Southey MC; Hibshoosh H; Santella RM; Terry MB
    Anticancer Res; 2017 Feb; 37(2):659-664. PubMed ID: 28179314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of extended family history in assessment of risk for breast and colon cancer.
    Solomon BL; Whitman T; Wood ME
    BMC Fam Pract; 2016 Sep; 17(1):126. PubMed ID: 27580697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methodological challenges for genome-based prediction of diseases].
    Foraita R; Jäger M; Pigeot I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Feb; 58(2):131-8. PubMed ID: 25432454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk management model for familial breast cancer: A new application using Fuzzy Cognitive Map method.
    Papageorgiou EI; Jayashree Subramanian ; Karmegam A; Papandrianos N
    Comput Methods Programs Biomed; 2015 Nov; 122(2):123-35. PubMed ID: 26220142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Awareness of genetic testing for breast cancer risk among women with a family history of breast cancer: effect of women's information sources on their awareness.
    Meischke H; Bowen D; Kuniyuki A
    Cancer Detect Prev; 2001; 25(4):319-27. PubMed ID: 11531008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines.
    Kotnik U; Peterlin B; Lovrecic L
    BMC Cancer; 2021 Jun; 21(1):665. PubMed ID: 34082720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the relationship between family history of breast cancer and knowledge of breast cancer genetic testing prerequisites.
    Mouchawar J; Byers T; Cutter G; Dignan M; Michael S
    Cancer Detect Prev; 1999; 23(1):22-30. PubMed ID: 9892987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial.
    Rubinstein WS; Acheson LS; O'Neill SM; Ruffin MT; Wang C; Beaumont JL; Rothrock N;
    Genet Med; 2011 Nov; 13(11):956-65. PubMed ID: 22075527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies.
    Evans DG; Harkness E; Lalloo F; Howell A
    J Med Genet; 2014 Sep; 51(9):573-80. PubMed ID: 25053764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Cancer Genetic Panel Testing on at-Risk Individuals.
    Frost AS; Toaff M; Biagi T; Stark E; McHenry A; Kaltman R
    Obstet Gynecol; 2018 Jun; 131(6):1103-1110. PubMed ID: 29742654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial clinical validation of Health Heritage, a patient-facing tool for personal and family history collection and cancer risk assessment.
    Baumgart LA; Postula KJ; Knaus WA
    Fam Cancer; 2016 Apr; 15(2):331-9. PubMed ID: 26711915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
    Yanes T; Young MA; Meiser B; James PA
    Breast Cancer Res; 2020 Feb; 22(1):21. PubMed ID: 32066492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results.
    Sardanelli F; Podo F; D'Agnolo G; Verdecchia A; Santaquilani M; Musumeci R; Trecate G; Manoukian S; Morassut S; de Giacomi C; Federico M; Cortesi L; Corcione S; Cirillo S; Marra V; ; Cilotti A; Di Maggio C; Fausto A; Preda L; Zuiani C; Contegiacomo A; Orlacchio A; Calabrese M; Bonomo L; Di Cesare E; Tonutti M; Panizza P; Del Maschio A
    Radiology; 2007 Mar; 242(3):698-715. PubMed ID: 17244718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based Genetic Testing for Precision Prevention.
    Evans O; Manchanda R
    Cancer Prev Res (Phila); 2020 Aug; 13(8):643-648. PubMed ID: 32409595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public attitudes towards preventive genomics and personal interest in genetic testing to prevent disease: a survey study.
    Vermeulen E; Henneman L; van El CG; Cornel MC
    Eur J Public Health; 2014 Oct; 24(5):768-75. PubMed ID: 24068545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation.
    Howe R; Miron-Shatz T; Hanoch Y; Omer ZB; O'Donoghue C; Ozanne EM
    J Genet Couns; 2015 Oct; 24(5):744-51. PubMed ID: 25519004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease.
    LaRusse S; Roberts JS; Marteau TM; Katzen H; Linnenbringer EL; Barber M; Whitehouse P; Quaid K; Brown T; Green RC; Relkin NR
    Genet Med; 2005 Jan; 7(1):48-53. PubMed ID: 15654228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.